Cargando…
Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 years
The COVID-19 Committee of the Lincei Academy has reviewed the scientific evidence supporting the efficacy and safety of existing and new drugs/biologics for the preventing and treating of COVID-19 and its complications. This position paper reports what we have learned in the field in the past 2 year...
Autores principales: | Remuzzi, Giuseppe, Schiaffino, Stefano, Santoro, Maria Gabriella, FitzGerald, Garret A., Melino, Gennaro, Patrono, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595217/ https://www.ncbi.nlm.nih.gov/pubmed/36304162 http://dx.doi.org/10.3389/fphar.2022.987816 |
Ejemplares similares
-
Long Covid: where we stand and challenges ahead
por: Mantovani, Alberto, et al.
Publicado: (2022) -
Editorial: Streaming Inflammation: From Damage to Healing and Resilience
por: Devchand, Pallavi R., et al.
Publicado: (2022) -
Editorial: Streaming inflammation: From damage to healing and resilience–Volume II
por: Devchand, Pallavi R., et al.
Publicado: (2023) -
The Pioglitazone Trek via Human PPAR Gamma: From Discovery to a Medicine at the FDA and Beyond
por: Devchand, Pallavi R., et al.
Publicado: (2018) -
Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators—What is the Evidence so far?
por: Schebb, Nils Helge, et al.
Publicado: (2022)